Health Care/Hospital

Silklife: Chula Researchers Transform Thai Silk into Medical Innovation

BANGKOK, Feb. 10, 2026 /PRNewswire/ -- Researchers at Chulalongkorn University  are redefining the role of Thai silk by developing silk protein into a versatile platform for medical products, aiming to reduce Thailand's reliance on imported biomaterials while creating...

2026-02-10 10:00 2060

Medical biotech Ferronova completes enrolment for gastric and oesophageal cancer image-guided surgery trial.

ADELAIDE, Australia, Feb. 10, 2026 /PRNewswire/ -- Australian company Ferronova announced today it has completed enrolment of patients for its two-year trial to progress commercialisation of FerroTrace, a novel nanoparticle image-guided surgery solution for hard-to-treat cancers. The technology ...

2026-02-10 09:30 2449

Johnson & Johnson Launches the First and Only Daily Disposable Multifocal Toric Contact Lens[1] for Astigmatic Adults living with Presbyopia

The brand also expands daily disposable options for astigmatic adults with the launch of ACUVUE® OASYS MAX 1-Day for ASTIGMATISM, bringing pioneering innovation that delivers visual clarity and comfort [+],[**],[2],[3] as vision needs evolve. SINGAPORE, Feb. 10, 2026 /PRNewswire/ -- Today, Johns...

2026-02-10 08:30 2625

Australia and New Zealand's Skin Cancer Governance Gap Exposed: 40% of Organisations Never Assessed Workforce Risk Despite 84% Believing Duty of Care Applies

New research reveals a critical blind spot in workplace health and safety compliance - even as boards demand better programs SYDNEY, Feb. 10, 2026 /PRNewswire/ -- A comprehensive new report on workplace skin cancer  screening in Australia ...

2026-02-10 06:23 2247

WAT Medical's EmeTerm Wearable Device Demonstrates Superior Control of Moderate to Severe Postoperative Nausea and Vomiting in JAMA Surgery-Published Clinical Trial

VANCOUVER, BC, Feb. 9, 2026 /PRNewswire/ -- WAT Medical is proud to announce the publication of a landmark randomized clinical trial inJAMA Surgery, one of the world's most reputable and high-impact surgical journals. The study confirms that the EmeTerm wristband — a wearable device utilizing tr...

2026-02-10 03:08 2676

MALAYSIA HEALTHCARE STRENGTHENS CROSS-BORDER COLLABORATION THROUGH STRATEGIC PARTNERSHIP WITH ONEHEALTH CAMBODIA

PHNOM PENH, Cambodia, Feb. 9, 2026 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC) marked the launch of Malaysia Healthcare Week Phnom Penh 2026 with a hospital introduction session in collaboration with OneHealth Cambodia. This engagement represents MHTC's first official initiative in ...

2026-02-09 22:00 3938

Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses

* Announces appointment of Claire M. Fraser, Ph.D., to its Board of Directors * Forms a global life sciences and diagnostics leader focused on high-volume testing in regulated applications * Announces formation of four divisions: Waters Analytical Sciences, Waters Biosciences, Waters Advance...

2026-02-09 21:44 2965

BioDlink Recognized by Client for Enabling the World's First Dual-Payload ADC to Enter Clinical Trials

* BioDlink received a formal letter of appreciation from Chengdu Kanghong Pharmaceutical Group for its contribution to advancing KH815, the world's first dual-payload antibody–drug conjugate (ADC) to enter clinical development. * BioDlink enabled IND approval 1.5 months ahead of schedule throu...

2026-02-09 21:00 2105

DIFF Biotech's Innovative Nasal Spray Influenza Vaccine Receives Clinical Trial Approval, Introducing a New Attenuation Pathway

HANGZHOU, China, Feb. 9, 2026 /PRNewswire/ -- Zhejiang Difference Biological Technology Co., Ltd. (DIFF Biotech) announced that its proprietary nasal spray influenza attenuated live vaccine, DIFF-flu, has recently received clinical trial approval as a Class 1.2 innovative vaccine fromChina's Nati...

2026-02-09 21:00 2084

'Made in India - The story of Desh Bandhu Gupta, Lupin and Indian Pharma' Book Launched in Mumbai

MUMBAI, India, Feb. 9, 2026 /PRNewswire/ -- Made in India, written by Sundeep Khanna and Manish Sabharwal, traces three remarkable journeys: the rise of India's pharma industry, the birth and evolution of Lupin (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) and the extraordinar...

2026-02-09 20:36 1683

AIA RESEARCH REVEALS INGRAINED HEALTH STEREOTYPES ARE HOLDING BACK WELLBEING IN ASIA

HONG KONG, Feb. 9, 2026 /PRNewswire/ -- AIA Group Limited ("AIA" or the "Group") today releases new research revealing that deeply entrenched physical, mental and financial health stereotypes shape attitudes and behaviours around wellbeing across Asia. The study(1) was conducted across Mainland C...

2026-02-09 16:08 3816

Peijia Medical Submits EU MDR CE Mark Registration Application for GeminiOne® TEER System

HONG KONG, Feb. 9, 2026 /PRNewswire/ -- Peijia Medical Limited (HKEX: 9996) today announced that it has formally submitted the European Union Medical Device Regulation (EU MDR) CE Mark registration application for its internally developedGeminiOne Transcatheter Edge-to-Edge Repair (TEER) System f...

2026-02-09 14:00 2153

CEVA ANNOUNCES STRATEGIC LEADERSHIP CHANGES IN ASIA-PACIFIC AND CHINA

LIBOURNE, France, Feb. 9, 2026 /PRNewswire/ -- Ceva Animal Health (Ceva), the world's fifth-largest animal health company operating in 110 countries, is implementing strategic organisational changes across Asia Pacific (APAC) and China to accelerate growth and drive operat...

2026-02-09 14:00 2360

Innovent Announces Strategic Collaboration with Lilly to Develop New Medicines Globally in Oncology and Immunology

SAN FRANCISCO and SUZHOU, China, Feb. 8, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metaboli...

2026-02-08 18:05 2894

Angel Yeast Indonesia Project: Strengthening Foundations through Technical Training and Building Consensus through Cultural Exchange

YICHANG, China, Feb. 6, 2026 /PRNewswire/ -- Angel Yeast Group (SH600298) recently welcomed 29 employees from Indonesia to its headquarters in Yichang, China, for a six-month structured training program. The initiative is designed to develop a cohort of skilled profes...

2026-02-07 09:31 7991

CHANDO Presents Decade-Long Skin Brightening Research at IMCAS

Research Introduces 577 Epigenetic Mechanism for Asian Skin SHANGHAI, Feb. 7, 2026 /PRNewswire/ -- The IMCAS World Congress 2026, an internationally recognized forum for aesthetic medicine and clinical research, opened on January 31 in Paris. As a global platform supporting collaboration in derm...

2026-02-07 01:45 3870

Neurophet Secures FDA 510(k) Clearance for "Neurophet AQUA AD Plus," Marking Its Third U.S. Regulatory Milestone

* Following AQUA and SCALE PET, the latest FDA clearance reinforces Neurophet's leadership in AI-based Alzheimer's disease imaging analysis * Advanced analysis of neuroimaging features associated with cerebral microbleeds and edema supports imaging-based clinical decision-making and accelera...

2026-02-06 22:00 6948

Kolmar Korea Wins Legal Battle Over Sun Care Technology Leakage Against Intercos Korea

- Korean courts order Intercos Korea to bear full legal costs, affirming both civil and criminal liability SEOUL, South Korea, Feb. 6, 2026 /PRNewswire/ -- Kolmar Korea has secured a decisive legal victory in a long-running dispute over the illegal leakage of proprietary sun care technologies in...

2026-02-06 21:30 4300

Samsung Biologics leads climate transparency with independent validation of Product Carbon Footprint system

* Samsung Biologics' PCF system validated in line with globally established ISO and PAS standards * Validation reflects continued efforts to establish credible carbon accounting in support of net-zero goals * Validated system provides reliable, consistent carbon footprint data for clients I...

2026-02-06 21:00 5960

Insilico Medicine Appoints Halle Zhang, PhD (Med), as Vice President, Clinical Development - Oncology

CAMBRIDGE, Mass., Feb. 6, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico")  (3696.HK),  a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced the appointment ofHalle Zhang, PhD (Med), as Vice President, Clinical Development – Oncology. Dr. Z...

2026-02-06 21:00 5173
12345 ... 858